Abstract:
The present invention relates to a multi-stage process for producing substituted, optically active alcohols, comprising an enzyme-catalyzed synthesis step, in particular a synthesis step which is catalyzed by an alcohol dehydrogenase. The inventive method is particularly suitable for producing phenylephrine, i.e. 3-[(1R)-1-hydroxy-2-methylamino-ethyl]-phenol.
Abstract:
The invention relates to the production of oxo-vinyl-ionol and O-protected derivatives thereof of formula (I), wherein R stands for hydrogen or an OH protecting group, for example a group Si(Ra)3, by reacting a compound of general formula (II), wherein R has the meanings previously specified for formula (I), i.e. beta-vinyl-ionol (formula (II), R = hydrogen) or an O-protected derivative thereof (formula (II), R = OH protecting group), with an oxidant in the presence of at least one transition metal, wherein the oxidant comprises at least one compound containing oxygen, which compound is selected from among hydrogen peroxide and organic hydroperoxides.
Abstract:
The invention pertains to processes to produce dry biomass of pyripyropene producer organisms, processes to obtain pyripyropenes from such dry biomass, as well as to processes to produce compounds of Formula III and/or Formula IV and/or Formula V from the pyripyropenes obtained from the dry biomass. The invention does further pertain to the dry biomass itself, as well as processes using said dry biomass to obtain pyripyropenes for the production of compounds of Formula III and/or Formula IV and/or Formula V, including processes using said dry biomass to obtain pyripyropenes or compounds of Formula III and/or Formula IV and/or Formula V in order to produce pest control compositions, in particular insecticides, comprising such compounds.
Abstract:
La presente invención se refiere a procesos para la sintetización de esclareolida y compuestos relacionados por ciclación biocatalítica de compuestos de ácido carboxílico poliinsaturado, en particular de ácido homofarnesílico y compuestos relacionados. La invención también se refiere a un proceso para la sintetización de ambróxido por medio de ciclación biocatalítica de ácido homofarnesílico por medio de la cual se obtiene esclareolida.
Abstract:
The invention relates to an environmentally friendly, resource-conserving, and economical method for producing astaxanthin esters of formula 1, wherein astaxanthin of formula 2 is doubly esterified with fatty acid chlorides of general formula 3. For this purpose, compounds 2 and 3 are reacted in an organic solvent in the presence of a nitrogen-containing base of general formula 4. The invention further relates to the non-therapeutic use of diester 1, wherein R stands for a residue that is selected from the group consisting of C13-C19 alkyl, C13-C19 alkenyl, C13-C19 alkdienyl, and C13-C19 alktrienyl, in the nourishment of humans or animals, and to diester 1 produced according to the method, for therapeutic use as a medication and as an ingredient for a medical preparation.
Abstract:
The invention relates to a process for continuously preparing di-C1-3-alkyl succinates by reacting succinic acid with an C1-3-alkanol in the presence of a fixed-bed heterogeneous acidic esterification catalyst in a tubular reactor at a temperature in the range of from 60 to 100°C, wherein a mixture, comprising succinic acid, C1-3-alkanol, mono-C1-3-alkyl succinate, di-C1-3-alkyl succinate and water, is formed in a mixing stage and fed to the entrance of the tubular reactor, and wherein 5 to 75% of the outlet flow rate of the tubular reactor are recycled directly to the mixing stage as a recycle stream, and the molar ratio of C1-3-alkanol to succinic acid added to the mixing zone, and not including the C1-3-alkanol and succinic acid at the recycle stream, being in the range of from 2.0 to 9.5. The invention furthermore relates to a process for separating the reactor effluent of an esterification of succinic acid with an C1-3-alkanol to give di-C1-3-alkyl succinates by distillation, wherein the separation is performed in a divided wall column in which C1-3-alkanol and water are removed in a top draw of the column, di-C1-3-alkyl succinate is removed in a side draw of the column, and wherein mono-C1-3-alkyl succinate and succinic acid are removed in a bottom draw of the column.